Dr. Eric Topol

One is that we have had

big investments in science and biotech to reverse aging.

And this is a lot of billionaires who, when they were young, they wanted to be rich.

And now that they're rich, they want to be young.

And they put lots of resources into these companies.

And some of them are doing really elegant science.

And

We can say that you can make a mouse or a rat that's old make it truly young.

I mean, yeah, it's extraordinary, but we're not at any data in people, right?

So that's one area that's really been moving quickly, and maybe someday we will have a way to reverse aging, but right now we don't.

We're not even close, and we also know that these various shots on goal each have different

liabilities and risks.

Like for example, the cellular reprogramming, we've seen tumors show up in mice and eroded.

So it's not a, you know, kind of a clear cut path to people.

Now, second bucket is the, what you were getting at is the longevity marketing.

All these companies are

There's clinics that charge up to $250,000 and you can get plasmapheresis and hyperbaric oxygen chambers and stem cells, all these unproven things.

No less, all these anti-aging supplements that have absolutely no data

to make these claims.

And so there's companies that are doing every test under the sun, total body, MRI.